Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Thailand - Delayed Quote THB

Chularat Hospital Public Company Limited (CHG.BK)

Compare
1.6700
-0.0100
(-0.60%)
At close: 4:19:39 PM GMT+7
Loading Chart for CHG.BK
  • Previous Close 1.6800
  • Open 1.6700
  • Bid 1.6600 x --
  • Ask 1.6700 x --
  • Day's Range 1.6300 - 1.6800
  • 52 Week Range 1.6300 - 3.0600
  • Volume 37,635,701
  • Avg. Volume 20,128,512
  • Market Cap (intraday) 18.37B
  • Beta (5Y Monthly) 0.06
  • PE Ratio (TTM) 18.44
  • EPS (TTM) 0.0900
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 0.10 (5.95%)
  • Ex-Dividend Date May 6, 2025
  • 1y Target Est 2.88

Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand. The company operates cancer treatment, aesthetic, social security, occupational health examination, and Thai traditional medicine centers, as well as drug auction systems. It also sells medicine and medical supplies. Chularat Hospital Public Company Limited was founded in 1986 is headquartered in Samut Prakan, Thailand.

www.chularat.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHG.BK

View More

Performance Overview: CHG.BK

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

CHG.BK
31.97%
MSCI WORLD (^990100-USD-STRD)
5.87%

1-Year Return

CHG.BK
41.29%
MSCI WORLD (^990100-USD-STRD)
2.67%

3-Year Return

CHG.BK
51.62%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

CHG.BK
11.54%
MSCI WORLD (^990100-USD-STRD)
97.01%

Compare To: CHG.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHG.BK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    18.48B

  • Enterprise Value

    17.37B

  • Trailing P/E

    19.16

  • Forward P/E

    16.81

  • PEG Ratio (5yr expected)

    1.83

  • Price/Sales (ttm)

    2.24

  • Price/Book (mrq)

    2.39

  • Enterprise Value/Revenue

    2.11

  • Enterprise Value/EBITDA

    9.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.38%

  • Return on Assets (ttm)

    7.78%

  • Return on Equity (ttm)

    12.18%

  • Revenue (ttm)

    8.48B

  • Net Income Avi to Common (ttm)

    965.22M

  • Diluted EPS (ttm)

    0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.81B

  • Total Debt/Equity (mrq)

    8.68%

  • Levered Free Cash Flow (ttm)

    913.5M

Research Analysis: CHG.BK

View More

Company Insights: CHG.BK

Research Reports: CHG.BK

View More

People Also Watch